Expression of the cysteinyl leukotriene receptors cysLT1 and cysLT2 in the airway structural cells Source: Eur Respir J 2005; 26: Suppl. 49, 346s Year: 2005
Increased expression of the cysteinil leukotriene 1 receptor (CysLT1-R) in the bronchial epithelium of smokers Source: Eur Respir J 2001; 18: Suppl. 33, 74s Year: 2001
The effects of a cysteinyl leukotriene receptor antagonist, pranlukast, on dendritic cell chemoattractants in the airways of subjects with asthma Source: Eur Respir J 2004; 24: Suppl. 48, 132s Year: 2004
Cysteinyl leukotriene-induced upregulation of tenascin and laminin β2 chain in human bronchial epithelial cells is mediated by the CysLT1 receptor Source: Eur Respir J 2007; 30: Suppl. 51, 217s Year: 2007
Down-regulation of SLPI by cysteinyl leukotrienes in human bronchial epithelial cells can be reverted by glucocorticoids Source: Annual Congress 2011 - Lung cell injury and repair Year: 2011
Effects of a newly developed dual CysLT1 and CysLT2 receptor antagonist, ONO-RS-531, on antigen- and leukotriene D4 -induced contractions of isolated human bronchi Source: Eur Respir J 2005; 26: Suppl. 49, 214s Year: 2005
Muscarinic receptors, leukotriene B4 production and neutrophilic inflammation in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 20s Year: 2004
Cysteinyl leukotriene receptor antagonist regulates vascular permeability by reducing VEGF expression Source: Eur Respir J 2004; 24: Suppl. 48, 129s Year: 2004
Effect of cysteinyl leukotriene receptor antagonist on airway wall remodeling Source: Eur Respir J 2002; 20: Suppl. 38, 304s Year: 2002
The CysLT1 receptor antagonist montelukast inhibits mast cell activation induced by inhaled leukotriene E4 in subjects with asthma Source: International Congress 2016 – Clinical and molecular studies in asthma Year: 2016
Cysteinyl leukotrienes cause down-regulation of β-tubulin isotype IV in human bronchial epithelial cells Source: Annual Congress 2009 - Highlighting the epithelial cell in lung disease: from COPD to cancer to acute lung injury Year: 2009
Effects of leukotriene receptor antagonists on airway mucus secretion Source: Eur Respir J 2001; 18: Suppl. 33, 245s Year: 2001
Inhibition of eosinophil migration by montelukast, a cysteinyl leukotriene receptor antagonist, through down regulation of plasmin activity Source: Eur Respir J 2004; 24: Suppl. 48, 36s Year: 2004
Leukotriene E4 increases tenascin production by human bronchial epithelial cells Source: Eur Respir J 2003; 22: Suppl. 45, 36s Year: 2003
Alternative transcripts of cysteinyl leukotriene receptor 1 in patients with bronchial asthma Source: Annual Congress 2007 - Novel mediators of cellular pathology Year: 2007
Leukotriene B4 receptor blockade increases apoptosis of monocyte-derived macrophages from patients with COPD and emphysema Source: Eur Respir J 2001; 18: Suppl. 33, 337s Year: 2001
Comparison of glucocorticoid and cysteinyl leukotriene receptor antagonist treatments in the airway remodeling induced by chronic airway inflammation in guinea pigs Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II Year: 2008
The pro-apoptotic effect of cysteinyl leukotriene receptor (CysLT-R) antagonist montelukast is mediated by CysLT-Rs expression on antigen-stimulated T cells Source: Eur Respir J 2003; 22: Suppl. 45, 100s Year: 2003
Proteome changes of human bronchial epithelial cells in response to leukotriene E4 and TGF-β1 Source: Annual Congress 2008 - Airway infection and host defence Year: 2008
The muscarinic receptors promote IL-8 release in airway epithelial cells via the pERK42/44 and NF-kB pathways Source: Eur Respir J 2006; 28: Suppl. 50, 746s Year: 2006